Literature DB >> 2576503

Neuronal Ca2+ channels and their regulation by excitatory amino acids.

R J Miller1, S N Murphy, S R Glaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576503     DOI: 10.1111/j.1749-6632.1989.tb12502.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Possible role for calmodulin and the Ca2+/calmodulin-dependent protein kinase II in postsynaptic neurotransmission.

Authors:  P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 2.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

Review 3.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons.

Authors:  K Furukawa; W Fu; Y Li; W Witke; D J Kwiatkowski; M P Mattson
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

5.  Glutamate agonists and [3H]GABA release from rat hippocampal slices: involvement of metabotropic glutamate receptors in the quisqualate-evoked release.

Authors:  R Janáky; V Varga; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

Review 6.  Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology.

Authors:  L Turski; W A Turski
Journal:  Experientia       Date:  1993-12-15

Review 7.  Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.

Authors:  Steve Vucic; Ulf Ziemann; Andrew Eisen; Mark Hallett; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-21       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.